It is deeply frustrating that the subcommittee is being told--six years after a statutory deadline--that it will be another year before FDA issues a final rule on medical gases.
Cindy Hyde-Smith
The Public Record
Cindy Hyde-Smith is an American politician serving as the junior United States Senator from Mississippi since April 2018. A member of the Republican Party, she was appointed to the Senate to fill the vacancy left by Thad Cochran's retirement. Hyde-Smith previously served as the Mississippi Commissioner of Agriculture and Commerce from 2012 to 2018, where she focused on agricultural issues and rural development.
Americans across the country, led by Concerned Women for America, the Nation's largest public policy organization for women, and other faith-based organizations continue to celebrate April as Faith Month. I commend this noble effort…
So the FDA, it's more of a legal issue of the procedure that happened than a safety issue of determining what drug is safe.
My main concern is an ectopic pregnancy that if the baby is not positioned which is deadly, or if she's further along that she's saying that she is.
I agree with the fifth circuit's description of this deeply disturbing this of really-not-looking-at-it or the head-in-the-sand approach.
So the FDA, it's more of a legal issue of the procedure that happened than a safety issue of determining what drug is safe.
I have heard from all of my local power companies in Mississippi. They are ringing me up.
It is deeply frustrating that the subcommittee is being told--six years after a statutory deadline--that it will be another year before FDA issues a final rule on medical gases.
In making its decision to eliminate the in-person dispensing requirement, none of the studies the FDA cited, which were largely conducted by abortion activists, studied the drugs under the new no-test tele-abortion regime.
My main concern is an ectopic pregnancy that if the baby is not positioned which is deadly, or if she's further along that she's saying that she is.
The law also requires the FDA to respond to petitions within a 180 days, but the FDA waited roughly 14 years and nearly 3 years to respond to citizens' petitions challenging FDA approval and deregulation of chemical abortion drugs.
I agree with the fifth circuit's description of this deeply disturbing this of really-not-looking-at-it or the head-in-the-sand approach.
The law also requires the FDA to respond to petitions within a 180 days, but the FDA waited roughly 14 years and nearly 3 years to respond to citizens' petitions challenging FDA approval and deregulation of chemical abortion drugs.
The law also requires the FDA to respond to petitions within a 180 days, but the FDA waited roughly 14 years and nearly 3 years to respond to citizens' petitions challenging FDA approval and deregulation of chemical abortion drugs.
In making its decision to eliminate the in-person dispensing requirement, none of the studies the FDA cited, which were largely conducted by abortion activists, studied the drugs under the new no-test tele-abortion regime.
My main concern is an ectopic pregnancy that if the baby is not positioned which is deadly, or if she's further along that she's saying that she is.
So the FDA, it's more of a legal issue of the procedure that happened than a safety issue of determining what drug is safe.
It is deeply frustrating that the subcommittee is being told--six years after a statutory deadline--that it will be another year before FDA issues a final rule on medical gases.
I just find it extremely concerning that under your watch the FDA allowed the dangerous life-ending, because they do kill the baby, chemical abortion drugs to be ordered by consumers through mail or purchased in retail pharmacies without…
But first of all, I want to tell you how much I appreciate your staff reaching out to us over the weekend with the Mississippi tornadoes.
You know, we are in the middle of planting corn, and the equipment is just gone.
I agree with the fifth circuit's description of this deeply disturbing this of really-not-looking-at-it or the head-in-the-sand approach.
So the FDA, it's more of a legal issue of the procedure that happened than a safety issue of determining what drug is safe.
My main concern is an ectopic pregnancy that if the baby is not positioned which is deadly, or if she's further along that she's saying that she is.
I agree with the fifth circuit's description of this deeply disturbing this of really-not-looking-at-it or the head-in-the-sand approach.





